HCCBP3MAG-58K

MILLIPLEX^® Human Circulating Cancer Biomarker Magnetic Bead Panel 3 - Cancer Multiplex Assay

Name: MILLIPLEX<SUP>®</SUP> Human Circulating Cancer Biomarker Magnetic Bead Panel 3 - Cancer Multiplex Assay
Brand: MM

Circulating Cancer Biomarker Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous analysis of multiple oncology biomarkers in various tumor types in human serum, plasma and cell culture samples.

Slide 1 of 5

Přihlásitk zobrazení cen stanovených pro organizaci a smluvních cen

O této položce

UNSPSC Code:

12161503

eCl@ss:

32161000

NACRES:

NA.84

To order a Milliplex® kit, please search for your analyte of interest.

Design And Price Your Kit

Hlavní dokumenty

Zobrazit celou dokumentaci

Přeskočit na

Technický servis

Potřebujete pomoc? Náš tým zkušených odborníků je vám k dispozici.

Dovolte nám, abychom vám pomohli

Quality Level

200

species reactivity

human

manufacturer/tradename

Milliplex^®

assay range

accuracy: 74-126%
standard curve range: 0.004-3 ng/mL
(Galectin-3)
standard curve range: 0.02-20 ng/mL
(Myeloperoxidase)
standard curve range: 0.03-25 nM
(Sex Hormone Binding Globulin)
standard curve range: 0.03-25 ng/mL
(Ferritin)
standard curve range: 0.07-50 ng/mL
(Catalase, Fibroblast Activation Protein α)
standard curve range: 0.1-75 ng/mL
(Melanoma Inhibitory Activity Protein)
standard curve range: 0.27-200 ng/mL
(Cathepsin D, IGFBP3)

technique(s)

multiplexing: suitable

detection method

fluorometric (Luminex xMAP)

shipped in

wet ice

Porovnat podobné položky

Zobrazit úplné porovnání

Zobrazit rozdíly

1 of 4

Tato položka	HCCBP2MAG-58K	HCCBP1MAG-58K	HCCB4MAG-58K
HCCBP3MAG-58K MILLIPLEX^® Human Circulating Cancer Biomarker Magnetic Bead Panel 3 - Cancer Multiplex Assay	HCCBP2MAG-58K MILLIPLEX^® Human Circulating Cancer Biomarker Magnetic Bead Panel 2 - Cancer Multiplex Assay	HCCBP1MAG-58K MILLIPLEX^® Human Circulating Cancer Biomarker Magnetic Bead Panel - Cancer Multiplex Assay	HCCB4MAG-58K MILLIPLEX^® Human Circulating Cancer Biomarker Magnetic Bead Panel 4 - Cancer Multiplex Assay
species reactivity human	species reactivity human	species reactivity human	species reactivity human
manufacturer/tradename Milliplex^®	manufacturer/tradename Milliplex^®	manufacturer/tradename Milliplex^®	manufacturer/tradename Milliplex^®
assay range accuracy: 74-126%, standard curve range: 0.02-20 ng/mL (Myeloperoxidase), standard curve range: 0.03-25 ng/mL (Ferritin), standard curve range: 0.1-75 ng/mL (Melanoma Inhibitory Activity Protein), standard curve range: 0.004-3 ng/mL (Galectin-3), standard curve range: 0.07-50 ng/mL (Catalase, Fibroblast Activation Protein α), standard curve range: 0.03-25 nM (Sex Hormone Binding Globulin), standard curve range: 0.27-200 ng/mL (Cathepsin D, IGFBP3)	assay range accuracy: 92-107%, standard curve range: 0.01-50 ng/mL (Extracellular matrix protein 1), standard curve range: 0.48-2,000 ng/mL (All other biomarkers)	assay range accuracy: 35-108%, standard curve range: 0.09-67 mU/mL (β-HCG), standard curve range: 0.7-500 pg/mL (IL-6), standard curve range: 1.3-1000 pg/mL (IL-8, TNFα), standard curve range: 2.7-2000 pg/mL (TRAIL, TGF-α), standard curve range: 6.9-5000 pg/mL (SCF)	assay range accuracy: 80-110%, standard curve range: 0.1-100 ng/mL (L1CAM), standard curve range: 0.1-100 ng/mL (Mesothelin), standard curve range: 0.3-250 ng/mL (Hepsin), standard curve range: 1.4-1,000 ng/mL (CD44), standard curve range: 1.4-1,000 ng/mL (Transglutaminase 2 (TGM2)), standard curve range: 13.7-10,000 pg/mL (EpCAM), standard curve range: 13.7-10,000 pg/mL (Midkine), standard curve range: 2.7-2,000 ng/mL (ALDH1A1), standard curve range: 20.6-15,000 pg/mL (Carbonic Anhydrase IX (CA9)), standard curve range: 27.4-20,000 pg/mL (Kallekrein-6), inter-assay cv: <10% intra-assay cv: <20%
Quality Level 200	Quality Level 200	Quality Level 200	Quality Level 200
technique(s) multiplexing: suitable	technique(s) multiplexing: suitable	technique(s) multiplexing: suitable	technique(s) multiplexing: suitable
shipped in wet ice	shipped in wet ice	shipped in wet ice	shipped in wet ice

General description

Circulating cancer biomarkers give insight beyond intracellular oncogenesis and into how the body responds to the presence of a tumor, the dysregulation of homeostasis, and the relationship between a tumor and its environment. Multianalyte panels have become essential tools that enable researchers to measure cancer biomarkers simultaneously, teasing out these relationships and applying them to understand tumor biology.

MILLIPLEX^® Human Circulating Biomarker Panel 3 is an 8-plex kit to be used for the simultaneous quantification or any or all of the following analytes in serum, plasma and tissue/cell lysate and culture supernatant samples: Galectin-3, Cathepsin D, Fibroblast activation protein alpha (FAP), Melanoma inhibitory activity protein (MIA), Myeloperoxidase, Sex hormone binding globulin (SHBG), Insulin like growth factor binding protein 3 (IGFBP3), and Ferritin. This kit uses a 96-well format, contains a lyophilized standard cocktail, two internal assay quality controls and can measure up to 38 samples in duplicate.

The Luminex^® xMAP^® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Circulating Cancer

Application

Analytes: Cathepsin D, Ferritin, Fibroblast Activation Protein (FAP), Galectin-3, IGFBP3, Melanoma Inhibitory Activty Protein (MIA), Myeloperoxidase (MPO), Sex Hormone Binding Globulin (SHGB)
Recommended Sample Type: Human serum, plasma or tissue/cell culture supernatants or lysates e
Recommended Sample Dilution: 25 μL of 1:50 diluted plasma or serum, or 25 μL of diluted tissue/cell lysate or culture supernatant per well (dilution factors may vary). Note: If IGFBP3 is included in the assay, then the recommended dilution for the assay is 1:200
Assay Run Time: Overnight (16-18 hr) at 2-4°C
Research Category: Cancer

Biochem/physiol Actions

Cross Reactivty
Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.

Features and Benefits

Design your multiplex kit by choosing available analytes within this panel.

Packaging

Everything you need in a single kit.

Preparation Note

Recommended storage for kit components is 2 - 8°C.

Analysis Note

SHBG Standard was calibrated against WHO standard 08/266 and 250 ng/mL standard was equivalent to 25 nM of WHO standard

Other Notes

Sensitivity: Refer to kit protocol for sensitivities of individual biomarkers.

Legal Information

Luminex is a registered trademark of Luminex Corp

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

pictograms

GHS06,GHS09

signalword

Danger

hcodes

H302 + H332,H311,H317,H319,H411

pcodes

P273 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1

Skladovací třída

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Osvědčení o analýze (COA)

Vyhledejte osvědčení Osvědčení o analýze (COA) zadáním čísla šarže/dávky těchto produktů. Čísla šarže a dávky lze nalézt na štítku produktu za slovy „Lot“ nebo „Batch“.

Již tento produkt vlastníte?

Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.

Navštívit knihovnu dokumentů

Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test.

Juan Pablo Hinestrosa et al.

Communications medicine, 2, 29-29 (2022-05-24)

Detecting cancer at early stages significantly increases patient survival rates. Because lethal solid tumors often produce few symptoms before progressing to advanced, metastatic disease, diagnosis frequently occurs when surgical resection is no longer curative. One promising approach to detect early-stage

Související obsah

Multiplex Cancer Assays for Cancer Research| MILLIPLEX^® Assays

Cancer biomarker detection through MILLIPLEX® multiplex cancer assays can accelerate studies of tumorigenic processes helping advance cancer research.

Questions

Reviews

No rating value

Active Filters

Náš tým vědeckých pracovníků má zkušenosti ve všech oblastech výzkumu, včetně přírodních věd, materiálových věd, chemické syntézy, chromatografie, analytiky a mnoha dalších..

Obraťte se na technický servis

MILLIPLEX® Human Circulating Cancer Biomarker Magnetic Bead Panel 3 - Cancer Multiplex Assay